DISCOVERING THE MOLECULAR MECHANISMS UNDERLYING CANNABIS-INDUCED INCREASED RISK OF SCHIZOPHRENIA: EVALUATION OF THE AKT/MTOR/S6 PATHWAY STATUS IN A DOUBLE HIT RODENT MODEL.

• Silvia Iñiguez-Barrio,
• Paula Unzueta-Larrinaga,
• Luis Callado,
• Rebeca Diez-Alarcia,
• Guadalupe Rivero,
• Leyre Urigüen

Affiliations

Silvia Iñiguez-Barrio

University of the Basque Country, Department Of Pharmacology, Leioa, Bizkaia, Spain

Paula Unzueta-Larrinaga

University of the Basque Country, Department Of Pharmacology, Leioa, Bizkaia, Spain; Biocruces Bizkaia Health Research Institute, Iib Biocruces Bizkaia, Barakaldo, Bizkaia, Spain

Luis Callado

University of the Basque Country, Department Of Pharmacology, Leioa, Bizkaia, Spain; Biocruces Bizkaia Health Research Institute, Iib Biocruces Bizkaia, Barakaldo, Bizkaia, Spain; CIBERSAM, Centro De Investigación Biomédica En Red De Salud Mental, Leioa, Bizkaia, Spain

Rebeca Diez-Alarcia

University of the Basque Country, Department Of Pharmacology, Leioa, Bizkaia, Spain; Biocruces Bizkaia Health Research Institute, Iib Biocruces Bizkaia, Barakaldo, Bizkaia, Spain; CIBERSAM, Centro De Investigación Biomédica En Red De Salud Mental, Leioa, Bizkaia, Spain

Guadalupe Rivero

University of the Basque Country, Department Of Pharmacology, Leioa, Bizkaia, Spain; Biocruces Bizkaia Health Research Institute, Iib Biocruces Bizkaia, Barakaldo, Bizkaia, Spain; CIBERSAM, Centro De Investigación Biomédica En Red De Salud Mental, Leioa, Bizkaia, Spain

Leyre Urigüen

University of the Basque Country, Department Of Pharmacology, Leioa, Bizkaia, Spain; Biocruces Bizkaia Health Research Institute, Iib Biocruces Bizkaia, Barakaldo, Bizkaia, Spain; CIBERSAM, Centro De Investigación Biomédica En Red De Salud Mental, Leioa, Bizkaia, Spain